WEBULL
WebtradeDownload

Amrize (SWX:AMRZ) Stock Can Profit Rebound Rewrite The Market View

Simply Wall St · 2d ago

Amrize stock has been grinding lower for weeks, down about 7% over the past three months. Yet Q2 landed with the kind of earnings snap that makes short term price action look impatient. The company delivered basic earnings per share of US$0.87 on revenue of US$3.5b, a clean rebound from the loss in Q1. That profit swing is now feeding into a bigger question for you as a shareholder: Is this the start of a more durable earnings run that eventually forces the market to reassess Amrize’s valuation, or just a sharp quarter in a still cautious story?

Is Amrize trading at a rare disconnect from its DCF estimate, or is the market correctly discounting its debt and margin profile? Compare the current share price against our valuation analysis for Amrize

Q2 2026 Amrize Earnings Summary

  • Revenue, Q2 2026 vs. Q2 2025: US$3.5b vs. US$3.2b (up about 8%)
  • Net Income, Q2 2026 vs. Q2 2025: US$478m vs. US$429m (up about 11%)
  • Basic EPS, Q2 2026 vs. Q2 2025: US$0.87 vs. US$0.78 (up about 12%)
  • Trailing Twelve Month Revenue, Q2 2026 vs. Q2 2025: US$12.2b vs. US$11.6b (up about 5%)

Prefer clear charts instead of another wall of earnings tables and ratio grids? View Amrize’s complete valuation picture in a visual, easy-to-scan format through the company report for Amrize.

SWX:AMRZ Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026
SWX:AMRZ Trailing 12-Month Revenue & Expenses Breakdown as at Aug 2026

Amrize bull case: earnings resilience gets an early test

Bulls argue Amrize can turn U.S. infrastructure, data center and LNG projects into a steadier earnings base, helped by capacity expansions and the ASPIRE efficiency program. Q2 revenue of US$3.5b and net income of US$478m, both higher than a year ago, show that volumes and mix are at least holding up while capacity projects are underway. The basic EPS of US$0.87, up from US$0.78, suggests early operating leverage rather than simple cost cutting. Trailing twelve month revenue at US$12.2b, above last year, points to some support from the multi year project pipeline. Recent deals in Texas and the Quebec modernization also line up with the thesis that Amrize is tightening integrated regional networks and positioning for policy backed demand. The quarter does not fully prove the long duration earnings story, but it does move several key milestones in the right direction.

Amrize bear case: execution, debt and cyclicality still in focus

Bears worry that Amrize is loading up on capital intensive projects and M&A while facing cyclical end markets and input cost risk. The Q2 profit swing from a Q1 loss into US$478m of net income and US$0.87 EPS challenges the idea that margins are structurally impaired. However, the share price is still down about 7% over 90 days, which indicates that investors are not yet convinced that this earnings step is durable. The US$600m U.S. capex program, the Quebec plant modernization and the Rapid Redi Mix acquisition all increase execution and integration risk, while also implying higher ongoing capital needs. Building Envelope is flagged as sensitive to housing and roofing cycles, and the current report does not give clear evidence that those exposures are fully insulated. The bear case is weakened on near term profitability, yet longer term concerns on capital intensity and cyclicality remain open.

After a swing from a Q1 loss into profit, are these capex heavy projects masking deeper balance sheet pressure? Review our risk analysis for Amrize which shows 1 important warning sign.

Stay Ahead Of Your Next Move With Amrize

If Amrize’s Q2 swing back to profit has your attention, register for free with Simply Wall St and add it to a Watchlist so you can track price against fair value and watch how the market responds to upcoming quarters. When you decide to build or adjust a position, keep on top of what matters with the Portfolio Command Center that highlights key developments without the usual noise. For a broader view of how other investors are thinking about Amrize and similar stocks, tap into the Community and see different perspectives side by side. By spotting potential catalysts and risks early, you give yourself a better chance to act with confidence and stay ahead of the market.

Seeking Fresh Alternatives Beyond Amrize?

Some of the most interesting breakout stories start quietly. Use these curated stock ideas before the crowd catches on and momentum moves past ideal entry ranges, and consider acting while opportunities remain accessible.

  • Spot income workhorses that aim to keep paying while prices move around, and scan a curated set of 440 dividend fortresses before yields potentially shift.
  • Track capital flowing into real assets by following curated producers through the 30 elite gold producer stocks while they still sit under the radar.
  • Watch the buildout of next generation computing by scanning hand picked enablers across the 26 quantum computing stocks while this niche remains relatively fresh and under followed.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.